Press Releases Search Search Category Topic Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Institute & Campus (1) (-) Press release (7) Science (4) 3R principles (replace, reduce, refine) (3) Alternative methods to animal studies (3) Alzheimer (17) Animal Research (30) Art (4) Artificial Intelligence (8) Bacteria (5) (-) Basic Research (5) BIH (13) BIMSB (53) Biochemistry & Proteomics (15) Brain Tumor (11) Campus (2) Campus Life (6) Cancer (79) Cardiovascular Research (72) Career (1) Cell Biology (26) Charité (18) Chorea Huntington (11) Clinical Research (8) Clinical Studies (4) Communication (1) Computational Biology (5) Construction (3) Corona Research (5) CRISPR/Cas9 (14) Data science (5) Developmental Biology (6) Diabetes (21) Disease-related Research (52) DZHK (13) ECRC (24) Epidemiology (4) ERC (13) (-) EU-Life (2) FMP (5) Gene Engineering (9) Gene Expression Regulation & RNA Biology (29) Genetics & Genomics (41) Green Campus (1) Helmholtz (2) History (6) Hypertension (40) Imaging (8) Immunology (37) Immunotherapy (9) Induced pluripotent stem cells (iPSCs) (6) Institute (9) Labor trifft Lehrer (1) Life Science Learning Lab (1) Long Night of Sciences (1) Lung Cancer (1) MDC-Forschung (4) Metabolism (10) Microbiome (1) Multiple sclerosis (1) Muscular dystrophy (6) NAKO (6) Neuroscience (73) Open Access (1) OpenScience (5) Organoids (12) Pain (1) Personalia (58) Pharmacology (1) PhD Students (3) Physiology (3) Postdocs (2) Prizes & Awards (54) Research Highlights (27) Responsible Research (5) science policy (2) Signal Transduction (20) Single-cell analysis (20) Stem Cell Biology (25) Structural Biology & Biophysics (6) Support for Scientists (2) Systems Biology (19) Teachers & Pupils (1) Technology Platforms (4) Technology Transfer (3) Translation (4) We at the MDC (1) Women in Science (2) Work and Family (3) 7 Results: Active Filter: Press releaseBasic ResearchEU-Life Sort: Result score Newest to oldest Oldest to newest Press Release No. 43 September 23, 2019 Berlin Open Letter from EU-LIFE: Doubling the budget for "Horizon Europe" EU-LIFE, the alliance of 13 leading Life Science Research Institutes in Europe urges the EU Council and the European Parliament to double Horizon Europe’s budget compared to Horizon 2020 (H2020), to 150 Billion Euros and within it, to double the budget for discovery research, including the well-proven European Research Council. Press Release No. 11 March 27, 2019 Berlin Improving the quality of biomedical research Professor John Ioannidis from Stanford University comes to Berlin as an Einstein BIH Visiting Fellow. Professor Martin Lohse, Scientific Director of the MDC, says he is looking forward to the discussions and exchanges with Ioannidis. Press Release No. 19 August 13, 2018 Berlin Joining forces for immune research In a new initiative, 23 groups from five Helmholtz Centers are joining forces to address some of the most complex problems in today's immunology in ways that can only be explored in collaboration. Press Release No. 10 April 18, 2018 Berlin Keeping the excitement under control James Poulet's lab listens to the activity of networks of single sensory neurons in the brain and discovered how a single signal from one cell manages to attract attention. Press Release No. 5 March 14, 2017 Berlin A European success story When the EU Commission founded the ERC in 2007, the new agency not only promised generous funding... Press Release No. 31 August 26, 2016 Berlin Successful recycling: Protein quality control in the cell Proteins perform a wide range of tasks within cells. For everything to run smoothly, the cell must... Press Release No. 27 November 04, 2015 Berlin Uptake mechanisms of cytostatics discovered How does a cytostatic like cisplatin or carboplatin actually get into the cell? Scientists at the MaxDelbrück Center for Molecular Medicine in the Helmholtz Association (MDC) and the Leibniz-Institut für Molekulare Pharmakologie (FMP) in Berlin, in cooperation with a Dutch group, have now succeeded in showing that the volume-regulated anion channel VRAC is 50 % responsible for active substance uptake. If one of the VRAC subunits LRRC8A or LRRC8D is down-regulated, cells take up considerably less of the anti-cancer drug. In addition to this finding, programmed cell death or apoptosis is also significantly disturbed when LRRC8A is missing. The researchers have thus identified a potential cause for therapy resistance.